InsiderTrades

Form 4 for NVAX NOVAVAX INC

Accepted 2023-12-18 00:00:00 ET · period of report 2023-12-14 · accession 0001209191-23-058990 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-12-18 2023-12-14 NVAX Trizzino John EVP, CCO, CBO F - Tax $5.69 -773 10.7K -7% -$4,398
D 2023-12-18 2023-12-14 NVAX Trizzino John EVP, CCO, CBO M - OptEx — +1,600 11.4K +16% —
D 2023-12-18 2023-12-14 NVAX Trizzino John EVP, CCO, CBO M - OptEx $0.00 -1,600 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-12-14 F D 773 $5.69 10,655 D — —
2 Common Common Stock 2023-12-14 M A 1,600 — 11,428 D — — (F1) The restricted stock units ("RSU"s) subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the December 14, 2020 grant date, in each case subject to continued employment through such vesting date.
3 Derivative Restricted Stock Units 2023-12-14 M D 1,600 $0.00 0 D — · — to — 1,600 Common Stock (F3) Each RSU represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. (F1) The restricted stock units ("RSU"s) subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the December 14, 2020 grant date, in each case subject to continued employment through such vesting date.